Becton Dickinson is the proud owner of CareFusion’s device business. The $12.2-billion deal is a mix of stock and cash, and ISI analyst Vijay Kumar tells Bloomberg combining forces will create a leader in medication management, acting as a “one-stop-shop” for hospitals.
Bloomberg notes that the deal took two years to progress from an idea to a transaction, and that BD already has a plan to carve out $250 million in costs by 2018.
